The recent Lancet Breastfeeding Series refers to new discoveries being made about breastmilk — such as its role in
gene expression — so it can be expected that Nestle will use the strategy of launching «new improved» formulas that are «closer to breastmilk» for decades to come (Nestle is currently investing heavily in
epigentics research).